Omega 3 fatty acids are polyunsaturated fatty acids, which are highly essential for the nutritional health of a person. It facilitates various critical functions in the human body, and is absorbed by the body through food. Structured lipids are triacylglycerols (TAG), which are essential components of the body composition and highly necessary in the daily food intake for a person. It essentially helps in maintain nitrogen balance during metabolism and acts as a readily available source of energy for peripheral tissues. The nutraceuticals omega 3 & structured lipids are thus growing in demand in the North American region, owing to the increased awareness among consumers regarding the health benefits of nutraceuticals.
The nutraceuticals omega 3 & structured lipids market in North America is one of the largest contributors to the global omega 3 & structured lipids market, having accounted for a share of 25% in 2013. The North American market for nutraceuticals omega 3 & structured lipids is forecast to grow at a CAGR of 6.6% during the forecast period, 2013 to 2018. The U.S. holds majority of the market in North America, owing to its 55.05% share in 2013. The Mexican segment is projected to be the fastest-growing market, at a CAGR of 8.6% from 2013 to 2018.
The most important drivers of the nutraceuticals omega 3 & structured lipids market are the growing health concerns and the expanding obese population in the region. 40% of the population in the U.S. has been observed to be obese, and are faced with the risk of being diagnosed with osteoporosis or rheumatoid arthritis. Moreover, the aging population is expanding in the U.S. and Canada. These factors have resulted in an increased awareness among people regarding the consumption of nutraceuticals and the associated benefits. Hence, the nutraceuticals omega 3 & structured lipids market is expected to grow significantly in the North American region. The major companies expected to cater to the rising demand for these nutraceuticals include Ingredion, Inc. (U.S.), CHR Hansen (Denmark), and BASF Performance Products (U.K.), among others.
The North American nutraceuticals omega 3 & structured lipids market report provides observations and analyses of the various segments and sub-segments of the market. The North American market has been segmented in terms of applications, and the major countries in the region. The countries considered for the comprehensive analysis of the regional market include the U.S., Canada, and Mexico. On the basis of applications, the market has been classified into animal feed, dietary supplements, functional foods, functional beverages, and personal care products. In 2013, the dietary supplements segment had a share of approximately 65% in the North American market, followed by the functional foods segment with a share of 16.7%.
1.1 Introduce the Market
1.2 Objective of the study
1.3 Market Definition and Scope of the study
1.3.1 Market Definition
1.3.2 Areas covered
1.3.3 Markets Covered
1.5 Research Methodology
1.5.1 Secondary sources
1.5.2 Primary Sources
1.5.3 Market estimation methodology (Top-down, bottom-up, data triangulation.)
1.5.4 Macro indicators for the study
1.7 List of Acronyms
2 Market Overview
3 Omega 3 & structured lipids (Nutraceuticals)-North America, By Geographies
3.1 Omega 3 & structured lipids (Nutraceuticals)-U.S.
3.1.1 Omega 3 & structured lipids (Nutraceuticals)-U.S., By MacroIndicators
184.108.40.206 Omega 3 & structured lipids (Nutraceuticals)-Population Projection-U.S.
3.2 Omega 3 & structured lipids (Nutraceuticals)-Canada
3.2.1 Omega 3 & structured lipids (Nutraceuticals)-Canada, By MacroIndicators
220.127.116.11 Omega 3 & structured lipids (Nutraceuticals)-Population Projection-Canada
3.3 Omega 3 & structured lipids (Nutraceuticals)-Mexico
3.3.1 Omega 3 & structured lipids (Nutraceuticals)-Mexico, By MacroIndicators
18.104.22.168 Omega 3 & structured lipids (Nutraceuticals)-Population Projection-Mexico
The Asia-Pacific Nutraceuticals market had been valued at $7,511.9 million in 2013, and is projected to reach $10,733 million by 2018, at a CAGR of 7.4%. Prebiotics, probiotics, amino acids, peptides & proteins, omega 3 & structured lipids, phytochemicals & plant extracts, minerals, vitamins are the types of Nutraceuticals.
|23 May 2014||$ 3500|
The Europe Nutraceuticals market was valued at $6,352.4 million in 2013, and is estimated to grow at an annual rate of 7.2% between 2013 and 2018, to reach a projected $8,985.9 million by 2018. The market for Europe Nutraceuticals can be segmented on the basis of applications, regions, and types.
|22 May 2014||$ 3500|
North America Nutraceuticals
The North American market for nutraceuticals was valued at $6.2 billion in 2013, and is projected to reach $8.8 billion by 2018, at a CAGR of 7.0%. The North American market comprises prebiotics, probiotics, amino acids, peptides, proteins, minerals, vitamins, fibers, and speciality carbohydrates.
|23 May 2014||$ 3500|